ABG-WTT Global Life Science Capital Partners GP

Latest statistics and disclosures from ABG-WTT Global Life Science Capital Partners GP's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Rayzebio, Medavail Holdings Ord, RPID, LUNG, and represent 100.00% of ABG-WTT Global Life Science Capital Partners GP's stock portfolio.
  • Added to shares of these 1 stock: Rayzebio (+$17M).
  • Started 1 new stock position in Rayzebio.
  • Reduced shares in these 1 stock: Medavail Holdings Ord (-$88M).
  • ABG-WTT Global Life Science Capital Partners GP was a net seller of stock by $-71M.
  • ABG-WTT Global Life Science Capital Partners GP has $21M in assets under management (AUM), dropping by 278.11%.
  • Central Index Key (CIK): 0001832108

Tip: Access up to 7 years of quarterly data

Positions held by ABG-WTT Global Life Science Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for ABG-WTT Global Life Science Capital Partners GP

ABG-WTT Global Life Science Capital Partners GP holds 4 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Rayzebio 83.0 $17M NEW 779k 22.20
 View chart
Medavail Holdings Ord 8.7 $1.8M -98% 301k 6.00
 View chart
Rapid Micro Biosystems Class A Com (RPID) 5.4 $1.1M 1.0M 1.08
 View chart
Pulmonx Corp (LUNG) 3.0 $622k 60k 10.33
 View chart

Past Filings by ABG-WTT Global Life Science Capital Partners GP

SEC 13F filings are viewable for ABG-WTT Global Life Science Capital Partners GP going back to 2020